24th ENS@T Scientific Meeting 2025
Endocrine Oncology is excited to announce a new special collection in collaboration with ENS@T 2025 - 24th Annual Meeting of the European Network for the Study of Adrenal Tumours (4-5 September 2025, Belgrade, Serbia). The Collection Editors invite submissions of original research, mini review, review articles, and case reports from speakers and delegates attending the meeting.
ENS@T was founded in 2002 by putting together three existing National Adrenal Networks from France, Germany and Italy, and teams from the United Kingdom, with the aim of improving understanding of adrenal tumours and patients’ management. In 2009, ENS@T became a membership-based society and a progressively increasing number of European clinicians and scientist interested in adrenal tumours joined the efforts of the Network. Nowadays, ENS@T includes over 500 members world-wide.
The ENS@T meeting is the annual highlight of the Network and a unique opportunity to engage the scientific community, including the world experts in adrenal tumours, to collaborate in multicentre research projects, and to network with colleagues, early-career academics and patient representatives.
The 2025 meeting will be held in Belgrade (Serbia), with an exceptional programme exploring the latest research on different types of adrenal tumours, such as incidentalomas, adrenal Cushing, primary aldosteronism, pheochromocytoma and paragangliomas, and adrenocortical carcinoma, from basic science to the latest advances in diagnosis and treatment. This meeting will be joint with the 4th EU COST Harmonisation meeting (www.goharmonisation.org).
As a multidisciplinary meeting, the workshop will involve basic scientists, geneticists, bioinformaticians, computational biologists, endocrinologists, oncologists, with the goal to update current knowledge, discuss ongoing challenges, and define new diagnostic and treatment requirements.
In this special collection, we hope to highlight the important topics discussed in the meeting.
There will be a £300 prize and certificate for ‘Best Paper’, selected by the Endocrine Oncology Editor-in-Chief Professor Justo Castaño and Deputy Editor Professor Simona Glasberg.
For more information and to submit your proposal, please email eo@bioscientifica.com.
Collection Editors
Associate Professor Cristina Ronchi
Cristina Ronchi is Reader (equiv. Associate Professor) in Endocrine Oncology at the University of Birmingham and Honorary Consultant Endocrinologist at the Queen Elizabeth Hospital Birmingham. She has long-standing clinical and translational expertise in endocrine tumors. Her research field focuses on molecular markers involved in the pathogenesis of adrenocortical tumours as well as in the prognosis and targeted treatment of patients with adrenocortical cancer. Dr Ronchi is first female President of the ENSAT, the European Network for the Study of Adrenal Tumors and is particularly active in research dissemination, communication and education, as well as public and patient engagement.
Dr Enzo Lalli, M.D.
Inserm Research Director (DR2) - Group Leader, IPMC CNRS – Inserm – Université Côte d’Azur, Coordinator, IIPACT CNRS International Research Network. Dr Lalli’s main research areas are gene expression regulation in endocrine oncology, molecular mechanisms of adrenal gland function and tumorigenesis and development of novel therapeutic approaches for endocrine cancers.
